X Pulmonary Disease in the Immunocompromised Host, An Issue of Clinics in Chest Medicine, 1st Edition

This special issue of Clinics in Chest Medicine delves into the complex challenges of diagnosing and managing pulmonary disease in immunocompromised patients. Under the expert editorial guidance of Drs. Scott Evans, Guang-Shing Cheng, Julio Ramirez, and Bashar Staitieh, the issue brings together a diverse group of leading specialists who explore both foundational and emerging aspects of care. Topics range from advanced imaging and molecular diagnostics to preventive strategies, therapeutic interventions, and long-term complications. The issue aims to equip clinicians with practical, evidence-based insights to improve outcomes in this high-risk population.

Key Features

• Comprehensive Coverage: Features 16 in-depth, clinically focused chapters on topics such as COVID-19, novel pulmonary infections, and host-directed therapies in immunocompromised patients.
• Transplant-Specific Focus: Includes detailed discussions on pulmonary complications in hematopoietic stem cell and solid organ transplant recipients.
• Steroid and Immunosuppressive Therapy: Reviews the unique pulmonary risks associated with chronic and high-dose corticosteroid use.
• Preventive and Adjunctive Strategies: Covers the role of vaccines, prophylactic interventions, and host-modulating therapies.
• Expert Perspectives: Authored by recognized leaders in pulmonology and infectious diseases who synthesize current research and clinical guidelines into practical recommendations.
• Clinical Relevance: Designed to support decision-making in everyday practice, with a focus on early diagnosis, targeted treatment, and management of complications in immunocompromised hosts.